Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0326 Transporter Info | ||||
Gene Name | SLC38A1 | ||||
Transporter Name | Sodium-coupled neutral amino acid transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 8 TF(s) Regulating This DT |
|||||
ATF2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-2 | Transcription Factor Info | ||||
Tissue |
Blood; Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-2 (ATF2) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
ATF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
BATF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [2] | ||||
TF Protein Name |
Basic leucine zipper transcriptional factor ATF-like | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Basic leucine zipper transcriptional factor ATF-like (BATF) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
CEBPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [2] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein alpha | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein alpha (CEBPA) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [3] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
CEBPD |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [4] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein delta | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein delta (CEBPD) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
CREB1 |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC38A1 gene in glioma condition | [5] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
Glioma [ICD11: 2A00.0] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Wistar rats | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) has been reported to activate the transcription of SLC38A1 gene in glioma condition, which leads to an increased expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Transcriptional Phenomenon2 |
Activation of SLC38A1 gene in health condition | [6] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Wistar rats | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) has been reported to activate the transcription of SLC38A1 gene in health condition, which leads to an increased expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Transcriptional Phenomenon3 |
Direct binding to SLC38A1 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Blood; Embryo; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
JUND |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [3] | ||||
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
Tissue |
Bone marrow; Brain; Breast; Cervix; Colon; Coronary artery; Embryo; Liver; Lung; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor JunD (JUND) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 9 TF(s) Regulating This DT |
|||||
ARNT |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC38A1 gene in breast cancer condition | [7] | ||||
TF Protein Name |
Aryl hydrocarbon receptor nuclear translocator | Transcription Factor Info | ||||
Affected Drug/Substrate |
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Aryl hydrocarbon receptor nuclear translocator (ARNT) has been reported to activate the transcription of SLC38A1 gene in breast cancer condition, which leads to an increased expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC38A1 gene | [3] | ||||
TF Protein Name |
Aryl hydrocarbon receptor nuclear translocator | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Aryl hydrocarbon receptor nuclear translocator (ARNT) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
ASCL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [4] | ||||
TF Protein Name |
Achaete-scute homolog 1 | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Achaete-scute homolog 1 (ASCL1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
HIF1A |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC38A1 gene in obesity condition | [8] | ||||
TF Protein Name |
Hypoxia-inducible factor 1-alpha | Transcription Factor Info | ||||
Studied Phenotype |
Obesity [ICD11: 5B81] | |||||
Tissue |
Brown adipose tissue | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC38A1 gene in obesity condition, which leads to an increased expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Transcriptional Phenomenon2 |
Activation of SLC38A1 gene in intrauterine growth restrictio condition | [9] | ||||
TF Protein Name |
Hypoxia-inducible factor 1-alpha | Transcription Factor Info | ||||
Studied Phenotype |
Intrauterine growth restrictio [ICD11: KA20.1] | |||||
Tissue |
Trophoderm | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human gestational choriocarcinoma cells (HTR-8) | |||||
Detailed Description |
Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC38A1 gene in intrauterine growth restrictio condition, which leads to an increased expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
LYL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [4] | ||||
TF Protein Name |
Protein lyl-1 | Transcription Factor Info | ||||
Tissue |
Blood; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein lyl-1 (LYL1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
MYC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC38A1 gene in embryonic stem cells condition | [10] | ||||
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Myc proto-oncogene protein (MYC) has been reported to bind to the transcription of SLC38A1 gene in embryonic stem cells condition, which leads to an affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
MYOD1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [2] | ||||
TF Protein Name |
Myoblast determination protein 1 | Transcription Factor Info | ||||
Tissue |
Myotube | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myoblast determination protein 1 (MYOD1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
TCF12 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [1] | ||||
TF Protein Name |
Transcription factor 12 | Transcription Factor Info | ||||
Tissue |
Blood; Breast; Embryo; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor 12 (TCF12) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
USF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [3] | ||||
TF Protein Name |
Upstream stimulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain; Colon; Embryo; Liver; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 1 (USF1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
USF2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [4] | ||||
TF Protein Name |
Upstream stimulatory factor 2 | Transcription Factor Info | ||||
Tissue |
Blood; Cervix; Embryo; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 2 (USF2) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Class1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
TFAP2A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC38A1 gene in health condition | [11] | ||||
TF Protein Name |
Transcription factor AP-2-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor AP-2-alpha (TFAP2A) has been reported to bind to the transcription of SLC38A1 gene in health condition, which leads to an affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
TFAP2C |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC38A1 gene in breast cancer condition | [12] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) has been reported to activate the transcription of SLC38A1 gene in breast cancer condition, which leads to an increased expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC38A1 gene | [2] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
AR |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [13] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC38A1 gene in . condition, which leads to a affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC38A1 gene | [1] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Tissue |
Breast; Cervix; Kidney; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Androgen receptor (AR) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
HNF4A |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC38A1 gene in health condition | [14] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC38A1 gene in health condition, which leads to an affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Transcriptional Phenomenon2 |
Binding to SLC38A1 gene in health condition | [15] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC38A1 gene in health condition, which leads to an affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
NR2F2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [4] | ||||
TF Protein Name |
COUP transcription factor 2 | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
COUP transcription factor 2 (NR2F2) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
PGR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [4] | ||||
TF Protein Name |
Progesterone receptor | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Progesterone receptor (PGR) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
PPARD |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC38A1 gene in myofibroblast condition | [16] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor delta | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Peroxisome proliferator-activated receptor delta (PPARD) has been reported to repress the transcription of SLC38A1 gene in myofibroblast condition, which leads to a decreased expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
PPARG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC38A1 gene in health condition | [17] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor gamma | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Uterine horn | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Polish Landrace-Duroc hybrid pigs | |||||
Detailed Description |
Peroxisome proliferator-activated receptor gamma (PPARG) has been reported to repress the transcription of SLC38A1 gene in health condition, which leads to a decreased expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [3] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
GATA3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [4] | ||||
TF Protein Name |
Trans-acting T-cell-specific transcription factor GATA-3 | Transcription Factor Info | ||||
Tissue |
Blood; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
GATA4 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC38A1 gene in gastric cancer condition | [18] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Metformin | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) has been reported to activate the transcription of SLC38A1 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC38A1 gene | [1] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Tissue |
Heart | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 8 TF(s) Regulating This DT |
|||||
BCL6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC38A1 gene in health condition | [19] | ||||
TF Protein Name |
B-cell lymphoma 6 protein | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
B-cell lymphoma 6 protein (BCL6) has been reported to activate the transcription of SLC38A1 gene in health condition, which leads to an increased expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
EGR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [2] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Early growth response protein 1 (EGR1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
KLF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [2] | ||||
TF Protein Name |
Krueppel-like factor 4 | Transcription Factor Info | ||||
Tissue |
Breast; Foreskin; Pancreatic ductal; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 4 (KLF4) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
KLF5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [2] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Tissue |
Colon; Pancreatic ductal; Stomach | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
KLF9 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [3] | ||||
TF Protein Name |
Krueppel-like factor 9 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 9 (KLF9) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [3] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Cervix; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
ZNF217 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC38A1 gene in breast cancer condition | [20] | ||||
TF Protein Name |
Zinc finger protein 217 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Zinc finger protein 217 (ZNF217) has been reported to bind to the transcription of SLC38A1 gene in breast cancer condition, which leads to an affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
ZNF263 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [1] | ||||
TF Protein Name |
Zinc finger protein 263 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 263 (ZNF263) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
PBX3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [4] | ||||
TF Protein Name |
Pre-B-cell leukemia transcription factor 3 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Pre-B-cell leukemia transcription factor 3 (PBX3) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
POU2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [1] | ||||
TF Protein Name |
POU domain, class 2, transcription factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
POU domain, class 2, transcription factor 1 (POU2F1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
E2F1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC38A1 gene in MCF7 cells | [11] | ||||
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor E2F1 (E2F1) has been reported to bind to the transcription of SLC38A1 gene in MCF7 cells, which leads to an affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC38A1 gene | [3] | ||||
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
Tissue |
Mesenchymal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F1 (E2F1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
E2F4 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC38A1 gene in health condition | [21] | ||||
TF Protein Name |
Transcription factor E2F4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor E2F4 (E2F4) has been reported to bind to the transcription of SLC38A1 gene in health condition, which leads to an affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Transcriptional Phenomenon2 |
Binding to SLC38A1 gene in health condition | [22] | ||||
TF Protein Name |
Transcription factor E2F4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor E2F4 (E2F4) has been reported to bind to the transcription of SLC38A1 gene in health condition, which leads to an affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [4] | ||||
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Cervix; Embryo; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F6 (E2F6) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [2] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Embryo; Lung; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [3] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Embryo; Endoderm; Liver; Lung; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
FOXM1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC38A1 gene in breast cancer condition | [23] | ||||
TF Protein Name |
Forkhead box protein M1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Forkhead box protein M1 (FOXM1) has been reported to activate the transcription of SLC38A1 gene in breast cancer condition, which leads to an increased expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC38A1 gene | [3] | ||||
TF Protein Name |
Forkhead box protein M1 | Transcription Factor Info | ||||
Tissue |
Blood; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein M1 (FOXM1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
FOXP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [4] | ||||
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
Tissue |
Blood; Embryo; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein P1 (FOXP1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 10 TF(s) Regulating This DT |
|||||
ELK1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [24] | ||||
TF Protein Name |
ETS domain-containing protein Elk-1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
ETS domain-containing protein Elk-1 (ELK1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
ELK3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [1] | ||||
TF Protein Name |
ETS domain-containing protein Elk-3 | Transcription Factor Info | ||||
Tissue |
Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
ETS domain-containing protein Elk-3 (ELK3) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
ERG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC38A1 gene in oncogenesis condition | [13] | ||||
TF Protein Name |
Transcriptional regulator ERG | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcriptional regulator ERG (ERG) has been reported to bind to the transcription of SLC38A1 gene in oncogenesis condition, which leads to an affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
ETS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [1] | ||||
TF Protein Name |
Protein C-ets-1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone; Bone marrow; Kidney; Lung; Prostate; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein C-ets-1 (ETS1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
FLI1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC38A1 gene in megakaryocytes condition | [25] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) has been reported to bind to the transcription of SLC38A1 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC38A1 gene | [2] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [1] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast; Liver; Lung; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
IRF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [4] | ||||
TF Protein Name |
Interferon regulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Blood; Pancreatic ductal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 1 (IRF1) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
IRF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [2] | ||||
TF Protein Name |
Interferon regulatory factor 4 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 4 (IRF4) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC38A1 gene in HL60 condition | [13] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) has been reported to bind to the transcription of SLC38A1 gene in HL60 condition, which leads to an affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
SPIB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [2] | ||||
TF Protein Name |
Transcription factor Spi-B | Transcription Factor Info | ||||
Tissue |
Blood; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor Spi-B (SPIB) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Class3.7: ARID domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
KDM5B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [3] | ||||
TF Protein Name |
Lysine-specific demethylase 5B | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Lysine-specific demethylase 5B (KDM5B) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Class6.2: STAT domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
STAT3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC38A1 gene in glioblastoma multiforme condition | [26] | ||||
TF Protein Name |
Signal transducer and activator of transcription 3 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Temozolomide | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Signal transducer and activator of transcription 3 (STAT3) has been reported to bind to the transcription of SLC38A1 gene in glioblastoma multiforme condition, which leads to an affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
STAT6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC38A1 gene in immune-mediated diseases condition | [27] | ||||
TF Protein Name |
Signal transducer and activator of transcription 6 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Signal transducer and activator of transcription 6 (STAT6) has been reported to activate the transcription of SLC38A1 gene in immune-mediated diseases condition, which leads to an increased expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Class6.3: p53 domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TP63 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC38A1 gene in epithelial to mesenchymal transition condition | [28] | ||||
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of SLC38A1 gene in epithelial to mesenchymal transition condition, which leads to an affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
RUNX1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC38A1 gene in health condition | [21] | ||||
TF Protein Name |
Runt-related transcription factor 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Runt-related transcription factor 1 (RUNX1) has been reported to bind to the transcription of SLC38A1 gene in health condition, which leads to an affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Transcriptional Phenomenon2 |
Binding to SLC38A1 gene in megakaryocytes condition | [25] | ||||
TF Protein Name |
Runt-related transcription factor 1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Runt-related transcription factor 1 (RUNX1) has been reported to bind to the transcription of SLC38A1 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
RUNX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC38A1 gene in prostate cancer condition | [29] | ||||
TF Protein Name |
Runt-related transcription factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Runt-related transcription factor 2 (RUNX2) has been reported to activate the transcription of SLC38A1 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
RUNX3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [4] | ||||
TF Protein Name |
Runt-related transcription factor 3 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Runt-related transcription factor 3 (RUNX3) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Class6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GRHL3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [3] | ||||
TF Protein Name |
Grainyhead-like protein 3 homolog | Transcription Factor Info | ||||
Tissue |
Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Grainyhead-like protein 3 homolog (GRHL3) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NFIC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [2] | ||||
TF Protein Name |
Nuclear factor 1 C-type | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear factor 1 C-type (NFIC) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
Class10.1: Other factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GTF2B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC38A1 gene | [1] | ||||
TF Protein Name |
Transcription initiation factor IIB | Transcription Factor Info | ||||
Tissue |
Cervix; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription initiation factor IIB (GTF2B) can directly bind to the SLC38A1 gene, which in turn affects the expression or function of the drug transporter Sodium-coupled neutral amino acid transporter 1. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.